Cargando…
3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis
Protothecosis is an unusual infection of both humans and animals caused by opportunistically pathogenic microalgae of the genus Prototheca. Until now, no standardized treatment protocols exist for the protothecal disease, boosted by a remarkable resistance of Prototheca spp. to a wide array of antim...
Autores principales: | Jagielski, Tomasz, Niedźwiecka, Katarzyna, Roeske, Katarzyna, Dyląg, Mariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917324/ https://www.ncbi.nlm.nih.gov/pubmed/29725298 http://dx.doi.org/10.3389/fphar.2018.00375 |
Ejemplares similares
-
The HK2 Dependent “Warburg Effect” and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate
por: Lis, Paweł, et al.
Publicado: (2016) -
Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma
por: Niedźwiecka, Katarzyna, et al.
Publicado: (2016) -
Drug Susceptibility Profiling of Prototheca Species Isolated from Cases of Human Protothecosis
por: Proskurnicka, Angelika, et al.
Publicado: (2023) -
Cutaneous Protothecosis
por: Mithari, Hershada S., et al.
Publicado: (2022) -
Cutaneous protothecosis in a dog successfully treated with oral itraconazole in pulse dosing
por: Gmyterco, Vanessa Cunningham, et al.
Publicado: (2023)